Search

Your search keyword '"Proudman, SM"' showing total 145 results

Search Constraints

Start Over You searched for: Author "Proudman, SM" Remove constraint Author: "Proudman, SM"
145 results on '"Proudman, SM"'

Search Results

1. The Effect of Body Fat Distribution on Systemic Sclerosis

2. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

Catalog

Books, media, physical & digital resources

4. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes

5. Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients

7. Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis

8. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

10. Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease Related Interstitial Lung Diseases

11. Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: The SPHInX study protocol

12. Subsets in systemic sclerosis: One size does not fit all

13. The association of low complement with disease activity in systemic sclerosis: a prospective cohort study

14. Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study

15. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: Provisional core sets of domains and instruments for use in clinical trials

17. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study

18. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study

20. Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs

21. Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?

22. Semiphysiologically based pharmacokinetic model of leflunomide disposition in rheumatoid arthritis patients

23. Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis?

24. The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity

25. Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis

26. Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma Cohort.

27. Pharmacokinetic-pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritis.

28. The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes.

29. Mortality estimates and excess mortality in rheumatoid arthritis.

30. Barriers and Enablers in the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review.

31. A survey of Australian rheumatologists' perspectives of nutrition needs in systemic sclerosis.

32. Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014-2020.

33. Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs.

34. The Effect of Body Fat Distribution on Systemic Sclerosis.

35. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.

36. Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium.

37. Quantitation of methotrexate polyglutamates in human whole blood, erythrocytes and leukocytes collected via venepuncture and volumetric absorptive micro-sampling: a green LC-MS/MS-based method.

38. The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trials.

39. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.

40. Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis.

42. Circulating Small Noncoding RNA Biomarkers of Response to Triple Disease-modifying Antirheumatic Drug Therapy in White Women With Early Rheumatoid Arthritis.

43. Repeat serological testing for anti-citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis.

44. The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy.

45. Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.

47. Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort.

48. The role of inflammatory markers in assessment of disease activity in systemic sclerosis.

49. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.

50. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.